Evidence map›Paper›PMID 32773263›Full record

ArticleSexual medicine2020

Vulvodynia Viewed From a Disease Prevention Framework: Insights From Patient Perspectives.

Valerie Webber, Michelle E Miller, Diana L Gustafson, Krisztina Bajzak

Open access · goldAbstract read
In one paragraph

Article in Sexual medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Botulinum toxin for provoked vestibulodynia.The Cochrane database of systematic reviews · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Pharmacological Treatments for Localized Provoked Vulvodynia: A Scoping Review.International journal of sexual health : official journal of the World Association for Sexual Health · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Valerie WebberDivision of Community Health and Humanities, Faculty of Medicine, Memorial University, St. John's, Newfoundland & Labrador, Canada.
Michelle E MillerDiscipline of Obstetrics and Gynecology, Memorial University, St. John's, Newfoundland & Labrador, Canada.
Diana L GustafsonDivision of Community Health and Humanities, Faculty of Medicine, Memorial University, St. John's, Newfoundland & Labrador, Canada.
Krisztina BajzakDiscipline of Obstetrics and Gynecology, Memorial University, St. John's, Newfoundland & Labrador, Canada. Electronic address: kbajzak@yahoo.com.
Newfoundland and Labrador Centre for Applied Health Research · CAMemorial University of Newfoundland · CASt. John’s Health Sciences Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPersons with vulvodynia (a chronic vulvar pain condition) suffer many barriers to diagnosis and treatment, several of which may be exacerbated by the sociocultural and geographical context in which they live.

aimWe drew on the experiences of patients with vulvodynia who were living in small urban and rural communities to learn what they perceived as the major barriers to diagnosis and treatment as well as to probe for possible solutions.

methodsFor this qualitative case study, we conducted 3 focus groups with a total of 10 participants, drawn from patients seen at our academic tertiary referral center, with a goal of understanding their lived experience with vulvodynia.

main outcome measuresThe patient dialogue was coded into themes and temporally grouped to illustrate struggles and victories in diagnosis and treatment.

resultsParticipants confirmed that healthcare provider knowledge and attitudes as well as system challenges (specialist and allied healthcare provider availability) are major barriers to timely diagnosis. Of novel interest are other factors that exacerbate distress and delay diagnosis such as patients' inadequate knowledge of sexual functioning and sociocultural messages regarding "normal" sexual activity. Our work suggests that a disease prevention framework that includes comprehensive sexual education before or at the onset of sexual activity may be of benefit in reducing the burden of vulvodynia when added to strategies to increase healthcare provider knowledge and improve access to effective treatments.

conclusionWhile healthcare provider knowledge and attitudes are often at the forefront of barriers to diagnosis, our study suggests that to minimize patient distress and expedite diagnosis, resources must also be directed to promoting comprehensive sexual health education. Webber V, Miller ME, Gustafson DL, et al. Vulvodynia Viewed From a Disease Prevention Framework: Insights From Patient Perspectives. Sex Med 2020;8:757-766.

Indexed as

Continuing Medical EducationHealth PersonnelPatient EducationSex EducationSexual HealthVulvar Pain

Identifiers

PMID32773263
PMCPMC7691876
OpenAlexW3047952954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.